Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.5 GBX | -19.81% | -19.81% | -30.14% |
05:58pm | Political turmoil hits euro and banks | AN |
01:08pm | Europe heads lower amid political turmoil in EU | AN |
Sales 2023 | 4.57M 5.82M | Sales 2024 * | 7.49M 9.54M | Capitalization | 48.7M 62.02M |
---|---|---|---|---|---|
Net income 2023 | -8M -10.19M | Net income 2024 * | -6M -7.64M | EV / Sales 2023 | 12.2 x |
Net cash position 2023 * | 6.16M 7.85M | Net cash position 2024 * | 976K 1.24M | EV / Sales 2024 * | 6.37 x |
P/E ratio 2023 |
-6.52
x | P/E ratio 2024 * |
-8.83
x | Employees | 51 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 48.52% |
Latest transcript on Arecor Therapeutics plc
1 day | -19.81% | ||
1 week | -19.81% | ||
Current month | -19.81% | ||
1 month | -6.59% | ||
3 months | -3.77% | ||
6 months | -35.93% | ||
Current year | -30.14% |
Managers | Title | Age | Since |
---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 49 | 14-12-31 |
Susan Lowther
DFI | Director of Finance/CFO | 65 | 18-12-31 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 07-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Smith
BRD | Director/Board Member | 78 | 21-04-12 |
Christine Soden
BRD | Director/Board Member | 66 | 21-04-30 |
Andrew Richards
CHM | Chairman | 64 | 21-04-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 127.5 | -19.81% | 47 288 |
24-06-07 | 159 | 0.00% | 2,000 |
24-06-06 | 159 | 0.00% | 12,784 |
24-06-05 | 159 | 0.00% | 11,590 |
24-06-04 | 159 | 0.00% | 11,722 |
Delayed Quote London S.E., June 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.14% | 61.96M | |
+47.85% | 57.87B | |
+41.65% | 40.25B | |
-7.19% | 39.94B | |
-5.96% | 28.54B | |
+12.26% | 26.4B | |
-20.40% | 19.33B | |
+30.06% | 12.4B | |
-0.84% | 12.23B | |
+24.00% | 12.2B |
- Stock Market
- Equities
- AREC Stock